Business
PDMR Acquisition of Shares and Additional Listing
PDMR Acquisition of Shares and Additional Listing.
About this update from Shield Therapeutics Plc
[{"type":"text","content":"\n \nRNS Number : 5467W Shield Therapeutics PLC 17 April 2019 \n\nShield Therapeutics plc\n(\"Shield\" or the \"Company\")\n \nPDMR Acquisition of Shares and Additional Listing\n \nLondon, UK, 17 April 2019. Shield Therapeutics plc (LSE:STX), a commercial stage pharmaceutical company with a focus on addressing iron deficiency with or without anaemia via its lead product Feraccru®, announces that it issued and allotted 223,690 Ordinary Shares of 1.5p each following the exercise of options under the Shield Therapeutics plc 2016 Long-Term Incentive Plan and the Shield Therapeutics Retention and Performance Share Plan.\n \nCarl Sterritt, Chief Executive Officer of the Company, has on 16 April 2019 exercised options held under The Shield Therapeutics plc 2016 Long-Term Incentive Plan to acquire 123,690 Ordinary Shares in the Company. Following the transaction, Mr Sterritt holds 10,198,951 shares, representing 8.71% of the Company's issued share capital. The remaining 100,000 Ordinary Shares were allotted following the exercise of options by other staff members.\n \nApplication has been made to the London Stock Exchange for the new Ordinary Shares to be admitted to trading on AIM. Admission is expected to be effective on 25 April 2019. The Ordinary Shares shall rank pari passu with the existing ordinary shares in the Company.\n \nFollowing admission, the Company's issued share capital will comprise 117,041,488 Ordinary Shares and each Ordinary Share carries one vote. There are no Ordinary Shares held in treasury and accordingly, the total number of voting rights is 117,041,488. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.\n \nNotification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them\n \n\n\n\n1\n\n\nDetails of the person discharging managerial responsibilities/person closely associated\n \n\n\n\n\na)\n\n\nName\n \n\n\nCarl Sterritt &nb...